Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Reed

Showing results (41-50 of 263) with videos related to

Pageof 27
Sort By:
Frontiers in Immunology|June 16, 2012
Adjuvants for Leishmania vaccines: from models to clinical applicationVanitha S Raman, Malcolm S Duthie, Christopher B Fox, et al.
Clinical and Vaccine Immunology : CVI|August 17, 2012
Effects on immunogenicity by formulations of emulsion-based adjuvants for malaria vaccinesChristopher B Fox, Susan L Baldwin, Thomas S Vedvick, et al.
Clinical and Vaccine Immunology : CVI|August 20, 2010
Identification of Mycobacterium tuberculosis antigens of high serodiagnostic valueGregory C Ireton, Rena Greenwald, Hong Liang, et al.
Vaccine|September 13, 2011
Immunomodulatory and physical effects of oil composition in vaccine adjuvant emulsionsChristopher B Fox, Susan L Baldwin, Malcolm S Duthie, et al.
Infection and Immunity|April 17, 2013
Regulatory actions of Toll-like receptor 2 (TLR2) and TLR4 in Leishmania donovani infection in the liverHenry W Murray, Yunhua Zhang, Yan Zhang, et al.
AAPS Pharmscitech|March 15, 2012
Immunomodulatory and physical effects of phospholipid composition in vaccine adjuvant emulsionsChristopher B Fox, Susan L Baldwin, Malcolm S Duthie, et al.
Pathogens (Basel, Switzerland)|November 11, 2022
Leishmaniasis Vaccines: Applications of RNA Technology and Targeted Clinical Trial DesignsMalcolm S Duthie, Bruna A S Machado, Roberto Badaró, et al.
Canadian Journal of Microbiology|March 31, 2004
Expression and purification of immunologically reactive DPPD, a recombinant Mycobacterium tuberculosis skin test antigen, using Mycobacterium smegmatis and Escherichia coli host cellsChao Liu, Eric Flamoe, Hong-Jing Chen, et al.
Journal of Clinical Microbiology|February 19, 2010
Application of an improved enzyme-linked immunosorbent assay method for serological diagnosis of canine leishmaniasisNuno Santarém, Ricardo Silvestre, Luís Cardoso, et al.
Plos One|February 20, 2014
GLA-AF, an emulsion-free vaccine adjuvant for pandemic influenzaChristopher H Clegg, Richard Roque, Lucy A Perrone, et al.
Pageof 27

Showing results (41-50 of 263) with videos related to

Sort By:
Pageof 27
Frontiers in Immunology|June 16, 2012
Adjuvants for Leishmania vaccines: from models to clinical applicationVanitha S Raman, Malcolm S Duthie, Christopher B Fox, et al.
Clinical and Vaccine Immunology : CVI|August 17, 2012
Effects on immunogenicity by formulations of emulsion-based adjuvants for malaria vaccinesChristopher B Fox, Susan L Baldwin, Thomas S Vedvick, et al.
Clinical and Vaccine Immunology : CVI|August 20, 2010
Identification of Mycobacterium tuberculosis antigens of high serodiagnostic valueGregory C Ireton, Rena Greenwald, Hong Liang, et al.
Vaccine|September 13, 2011
Immunomodulatory and physical effects of oil composition in vaccine adjuvant emulsionsChristopher B Fox, Susan L Baldwin, Malcolm S Duthie, et al.
Infection and Immunity|April 17, 2013
Regulatory actions of Toll-like receptor 2 (TLR2) and TLR4 in Leishmania donovani infection in the liverHenry W Murray, Yunhua Zhang, Yan Zhang, et al.
AAPS Pharmscitech|March 15, 2012
Immunomodulatory and physical effects of phospholipid composition in vaccine adjuvant emulsionsChristopher B Fox, Susan L Baldwin, Malcolm S Duthie, et al.
Pathogens (Basel, Switzerland)|November 11, 2022
Leishmaniasis Vaccines: Applications of RNA Technology and Targeted Clinical Trial DesignsMalcolm S Duthie, Bruna A S Machado, Roberto Badaró, et al.
Canadian Journal of Microbiology|March 31, 2004
Expression and purification of immunologically reactive DPPD, a recombinant Mycobacterium tuberculosis skin test antigen, using Mycobacterium smegmatis and Escherichia coli host cellsChao Liu, Eric Flamoe, Hong-Jing Chen, et al.
Journal of Clinical Microbiology|February 19, 2010
Application of an improved enzyme-linked immunosorbent assay method for serological diagnosis of canine leishmaniasisNuno Santarém, Ricardo Silvestre, Luís Cardoso, et al.
Plos One|February 20, 2014
GLA-AF, an emulsion-free vaccine adjuvant for pandemic influenzaChristopher H Clegg, Richard Roque, Lucy A Perrone, et al.
Pageof 27